Clinical Research Priorities for Thalassemia
Wednesday, May 20, 2009 -
Thursday, May 21, 2009
The goal of this meeting was to allow interested individuals to express their opinions about the directions clinical research in thalassemia should take, given past experiences and limitations imposed by NIH budgets and regulatory requirements. These proceedings also served as the basis of a Request for Applications (RFA) for clinical trials in thalassemia.
Dr. Harvey Luksenburg, NHLBI 301-451-6766
National Heart, Lung, and Blood Institute
From the National Center for Advancing Translational Sciences
From the National Institutes of Health